To characterize the distribution and toxicity of phosphorothioate antisense oligodeoxynucleotides ([S]ODNs) in vivo, the mice, previously injected with BV173 leukemic cells (Philadelphia chromosome-positive chronic myeloid leukemia blast-crisis), received intravenously 26-mer BCR-ABL antisense oligodeoxynucleotides (1 mg/mouse/day) for 9 consecutive days. Our investigation revealed that [S]ODNs were distributed to almost all organs except the brain with the highest level in the liver, spleen and kidneys. They were also detected in CD10+ leukemic cells isolated from spleen and bone marrow. Intracellular distribution assay showed the presence of [S]ODNs most prominently in nuclear and cytoplasmic fractions. Our data demonstrated no significan...
Antisense oligomers may be used for carrying radiation source into a specific location inside a tumo...
Antisense oligonucleotides (ASOs) are chemically modified nucleic acids with therapeutic potential, ...
We previously modulated, by conjugating a single cholesterol, plasma protein binding and liver cell ...
It has been suggested that binding of phosphorothioate oli-godeoxynucleotides (P5S ODNs) to macropha...
The therapeutic activity of antisense oligodeoxynucleotides (ODNs) often is impaired due to prematur...
n vitro, uniformly modified oligonucleotide N3'-->P5' phosphoramidates are apparently more potent an...
When injected into SCID mice, the Philadelphia chromosome-positive chronic myeloid leukemia-blast cr...
Transport of phosphorothioate oligonucleotides in the kidney: Implications for molecular therapy. Th...
Antisense oligodeoxyribonucleotides (ODNs) are now being extensively investigated in an attempt to a...
Antisense oligonucleotides represent a novel therapeutic pnn-ciple for designing drugs against vario...
AIM To evaluate antihepatoma effect of antisense phosphorothioate oligodeoxyribonucleotides (S-ODNs)...
ISIS 2302 is a phosphorothioate oligodeoxynucleotide with a sequence complementary to the mRNA of hu...
Antisense oligonucleotides (AONs) are being developed as RNA therapeutic molecules for Duchenne musc...
To investigate the possibility of using radioiodine labeled framework region (FR) antisense oligonuc...
Antisense oligodeoxyribonucleotides (ODNs) can specifically inhibit gene expression, but their appli...
Antisense oligomers may be used for carrying radiation source into a specific location inside a tumo...
Antisense oligonucleotides (ASOs) are chemically modified nucleic acids with therapeutic potential, ...
We previously modulated, by conjugating a single cholesterol, plasma protein binding and liver cell ...
It has been suggested that binding of phosphorothioate oli-godeoxynucleotides (P5S ODNs) to macropha...
The therapeutic activity of antisense oligodeoxynucleotides (ODNs) often is impaired due to prematur...
n vitro, uniformly modified oligonucleotide N3'-->P5' phosphoramidates are apparently more potent an...
When injected into SCID mice, the Philadelphia chromosome-positive chronic myeloid leukemia-blast cr...
Transport of phosphorothioate oligonucleotides in the kidney: Implications for molecular therapy. Th...
Antisense oligodeoxyribonucleotides (ODNs) are now being extensively investigated in an attempt to a...
Antisense oligonucleotides represent a novel therapeutic pnn-ciple for designing drugs against vario...
AIM To evaluate antihepatoma effect of antisense phosphorothioate oligodeoxyribonucleotides (S-ODNs)...
ISIS 2302 is a phosphorothioate oligodeoxynucleotide with a sequence complementary to the mRNA of hu...
Antisense oligonucleotides (AONs) are being developed as RNA therapeutic molecules for Duchenne musc...
To investigate the possibility of using radioiodine labeled framework region (FR) antisense oligonuc...
Antisense oligodeoxyribonucleotides (ODNs) can specifically inhibit gene expression, but their appli...
Antisense oligomers may be used for carrying radiation source into a specific location inside a tumo...
Antisense oligonucleotides (ASOs) are chemically modified nucleic acids with therapeutic potential, ...
We previously modulated, by conjugating a single cholesterol, plasma protein binding and liver cell ...